The Enterprise Value as of June 2026 (TTM) for Iovance Biotherapeutics, Inc. (IOVA) is 1.31B

According to Iovance Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.31B. This represents a change of 49.77% compared to the average of 874.00M of the last 4 quarters.

Iovance Biotherapeutics, Inc. (IOVA) Historical Enterprise Value (quarterly & annually)

How has IOVA Enterprise Value performed in the past?

The mean historical Enterprise Value of Iovance Biotherapeutics, Inc. over the last ten years is 1.98B. The current 1.31B Enterprise Value has changed 6.50% with respect to the historical average. Over the past ten years (40 quarters), IOVA's Enterprise Value was at its highest in in the December 2020 quarter at 6.78B. The Enterprise Value was at its lowest in in the December 2016 quarter at 265.33M.

Iovance Biotherapeutics, Inc. (IOVA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Iovance Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Iovance Biotherapeutics, Inc. (IOVA) Average Enterprise Value

How has IOVA Enterprise Value performed in the past?

The current Enterprise Value of Iovance Biotherapeutics, Inc. (IOVA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Iovance Biotherapeutics, Inc. (IOVA) Enterprise Value vs. Peers

How is IOVA’s Enterprise Value compared to its peers?

Iovance Biotherapeutics, Inc.’s Enterprise Value is greater than Ginkgo Bioworks Holdings, Inc. (782.25M), greater than MBX Biosciences, Inc. Common Stock (1.15B), less than Erasca, Inc. (4.37B), greater than Replimune Group, Inc. (686.64M), greater than MeiraGTx Holdings plc (904.12M), greater than MoonLake Immunotherapeutics (1.18B), greater than Vir Biotechnology, Inc. (1.26B), greater than CytomX Therapeutics, Inc. (458.11M), greater than Astria Therapeutics, Inc. (626.31M), less than ArriVent BioPharma, Inc. Common Stock (1.36B),

Build a custom stock screener for Iovance Biotherapeutics, Inc. (IOVA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Iovance Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Iovance Biotherapeutics, Inc. (IOVA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Iovance Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.